CJC-1295 Reconstitution Protocol (Research Only)

Overview of CJC-1295 as a GHRH Analog

CJC-1295 is a synthetic 29-amino acid tetrasubstituted peptide analog of growth hormone-releasing hormone (GHRH). In preclinical models, GHRH analogs act directly on the pituitary GHRH receptors to stimulate the synthesis and pulsatile release of endogenous growth hormone (GH). This upstream activation subsequently elevates systemic insulin-like growth factor 1 (IGF-1) levels, rendering CJC-1295 a key compound in cellular proliferation, protein synthesis, and general tissue repair research.

Unlike native GHRH(1-29), which exhibits a rapid plasma half-life of less than 12 minutes in animal models due to fast enzymatic cleavage by dipeptidyl peptidase IV (DPP-IV), CJC-1295 incorporates specific amino acid substitutions (D-Ala, Gln, Ala, and Leu at positions 2, 8, 15, and 27, respectively). In its Drug Affinity Complex (DAC) formulation, CJC-1295 covalently binds to circulating serum albumin, extending its biological half-life significantly. Regardless of whether researchers utilize CJC-1295 DAC or non-DAC variants for short-acting protocols, mastering precise cjc-1295 reconstitution techniques is critical to preserve bioactivity and prevent peptide aggregation.

Chemical Structure, Lyophilization, and Solubility Profile

PX1 Research supplies CJC-1295 as a lyophilized (freeze-dried) cake or powder sealed under vacuum or inert gas atmosphere. Lyophilization removes water molecules via sublimation, stabilizing the tertiary structure of the peptide against hydrolytic cleavage during transport and long-term storage.

CJC-1295 possesses a molecular weight of approximately 3367.97 Da (without DAC) or 4975.69 Da (with DAC). The peptide is highly soluble in polar aqueous solvents, particularly diluted acidic solutions or buffered saline solutions containing preservative agents like 0.9% benzyl alcohol. Because lyophilized peptides are prone to mechanical degradation when subjected to high shear forces, reconstitution must be carried out slowly without aggressive physical agitation.

Required Laboratory Reagents and Sterile Equipment

To perform a clean, sterile reconstitution of CJC-1295 in a laboratory context, researchers must assemble all necessary consumables inside a Class II Biosafety Cabinet or laminar flow hood to maintain aseptic conditions. Essential supplies include:

- Lyophilized CJC-1295 vial (PX1 Research product catalog) - Sterile bacteriostatic water (0.9% benzyl alcohol preserved) - Sterile 70% isopropyl alcohol wipes - Sterile 1 mL or 3 mL polypropylene syringes fitted with 21G to 25G precision needles - Calibrated micropipettes and sterile filter tips for micro-volume analytical sampling - Biohazard waste container and sharps disposal container

It is strongly recommended to utilize bacteriostatic water rather than sterile unpreserved water for injection (WFI) if the reconstituted compound will be sampled multiple times over an extended research timeframe. The presence of 0.9% benzyl alcohol inhibits microbial proliferation during multi-entry laboratory sampling.

Step-by-Step CJC-1295 Reconstitution Protocol

1. **Preparation and Sanitization**: Allow the lyophilized CJC-1295 vial and the bacteriostatic water diluent to reach room temperature (20°C to 25°C) inside the biosafety cabinet. Swab the rubber stoppers of both vials thoroughly with 70% isopropyl alcohol wipes and allow them to air-dry for at least 30 seconds.

2. **Aspiration of Diluent**: Using a sterile syringe, draw air equal to the intended volume of diluent (e.g., 2.0 mL). Inject the air into the bacteriostatic water vial to equalize pressure, then invert the vial and aspirate the precise target volume of diluent.

3. **Controlled Solvent Transfer**: Position the needle tip against the inner glass wall of the CJC-1295 vial. Slowly depress the plunger, allowing the bacteriostatic water to stream down the side of the glass rather than spraying directly onto the lyophilized peptide cake. Direct high-pressure impact can disrupt delicate peptide chains.

4. **Pressure Equalization**: Before withdrawing the needle, allow excess pressure inside the sealed CJC-1295 vial to equalize by drawing back slightly on the syringe plunger until neutral pressure is achieved.

5. **Dissolution and Solubilization**: Gently swirl the vial in a smooth circular motion. Do NOT shake, invert violently, or vortex the vial. Complete dissolution typically occurs within 30 to 120 seconds, yielding a completely clear, colorless solution devoid of visible particulates or cloudy suspension.

Dilution Math and Concentration Calculations

Accurate concentration calculations are vital for precise micro-dosing in cell culture assays or preclinical animal models. The final concentration ($C$) of the reconstituted solution depends on the mass of the lyophilized peptide ($M$) and the total volume of diluent added ($V$), expressed by the formula $C = M / V$.

For example, if a laboratory reconstitutes a 2 mg (2000 mcg) vial of CJC-1295 with 1.0 mL of bacteriostatic water, the resulting concentration is: $$\text{Concentration} = \frac{2000\text{ mcg}}{1.0\text{ mL}} = 2000\text{ mcg/mL}$$ If using a standard 100-unit laboratory graduation syringe (where 1.0 mL = 100 units), each 1-unit mark represents 20 mcg of CJC-1295. Alternatively, adding 2.0 mL of diluent to a 5 mg (5000 mcg) vial yields a final concentration of 2500 mcg/mL (25 mcg per unit).

Researchers conducting complex serial dilutions or volumetric assays can consult our interactive peptide reconstitution calculator to verify laboratory math prior to pipetting.

Bacteriostatic Water Handling and Sterile Technique

Maintaining aseptic conditions during reconstitution is essential for preserving the chemical integrity of the target peptide and avoiding biological contamination in cell cultures or animal studies. Bacteriostatic water contains 0.9% benzyl alcohol, which acts as a bacteriostatic preservative to prevent bacterial replication.

When withdrawing aliquots from a reconstituted CJC-1295 vial over multiple experimental timepoints, always wipe the rubber septum with fresh 70% isopropyl alcohol. Never reuse needles or pipettes across multiple vials. If the diluent or reconstituted solution exhibits turbidity, discoloration, or precipitation at any point during handling, discard the sample in accordance with institutional laboratory safety protocols.

Comparative Analysis: CJC-1295 vs. Related Secretagogues

In preclinical GH research, CJC-1295 is frequently evaluated alongside or in combination with other growth hormone secretagogues to study synergistic receptor signaling pathways. Understanding structural and physiological differences helps researchers select the optimal compound class for specific models.

While CJC-1295 operates directly on GHRH receptors, ghrelin/growth hormone secretagogue receptor (GHSR-1a) agonists like ipamorelin act through an independent, complementary mechanism. Combining GHRH analogs with GHSR agonists often demonstrates enhanced pulsatile GH release in rodent models. Conversely, other GHRH derivatives such as tesamorelin feature specialized N-terminal modifications designed for targeted lipolysis studies, whereas early-generation analogs like sermorelin represent the truncated 29-amino-acid core without the metabolic stabilization modifications found in CJC-1295. For broader comparative data across these peptides, visit our comprehensive GHRH analogs research hub.

Storage Parameters, Temperature Sensitivity, and Stability

Proper storage conditions are mandatory to minimize peptide degradation mechanisms, such as oxidation, deamidation, and peptide bond cleavage.

- **Lyophilized Powder**: Unreconstituted CJC-1295 should be stored in a freezer at -20°C for long-term stability (up to 24 months). If stored at 2°C to 8°C, the lyophilized powder remains stable for up to 90 days. Avoid exposing lyophilized vials to direct light or ambient moisture.

- **Reconstituted Solution**: Once reconstituted with bacteriostatic water, CJC-1295 liquid solutions must be refrigerated at 2°C to 8°C (36°F to 46°F) and are generally stable for up to 28 days. Avoid subjecting reconstituted liquids to freeze-thaw cycles, as crystal formation causes mechanical shear stress that disrupts peptide chains.

For additional stability studies and solvent compatibility frameworks, explore the centralized PX1 Research Library.

Analytical Quality Control and COA Verification at PX1 Research

PX1 Research ensures that every batch of CJC-1295 synthesized in our USA facilities undergoes strict analytical validation. Products are verified in ISO 17025 accredited laboratories utilizing high-performance liquid chromatography (HPLC) to guarantee purity levels exceeding 98.0%, paired with mass spectrometry (MS) to confirm exact molecular weight and sequence identity.

Furthermore, our research peptides are subject to Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain strictly below <0.05 EU/mg. Institutional researchers requiring lot-specific Certificates of Analysis (COA) or purchasing in bulk for large-scale preclinical trials can establish direct accounts via our wholesale customer portal.